Y Katsuda, K Egashira, H Ueno, Y Arai, Y Akatsuka, T Kuga, H Shimokawa, A Takeshita
Index: Am. J. Physiol. 270(6 Pt 2) , H2210-5, (1996)
Full Text: HTML
The opening of ATP-sensitive K+ (K+ATP) channels contributes to the mechanism of metabolic coronary vasodilation. The aim of the present study was to determine whether K+ATP channel opener pinacidil augments coronary vasodilation induced by beta-adrenoceptor stimulation. In anesthetized dogs, coronary vasodilation in response to intracoronary infusion of a beta 1-adrenoceptor agonist denopamine, selective beta 2-adrenoceptor stimulation with isoproterenol after bisoprolol or nitroglycerin was studied before and during simultaneous intracoronary infusion of pinacidil at a dose of 1 microgram/min, which had no effect on basal hemodynamics. Pinacidil augmented the denopamine-induced increase in coronary blood flow (CBF) from 38 +/- 9 to 66 +/- 16% (P < 0.05) but did not affect the denopamine-induced by isoproterenol or nitroglycerin. Thus pinacidil selectively augmented beta 1-adrenoceptor-mediated coronary vasodilation. These observations suggest that the K+ATP channel opener pinacidil may increase myocardial perfusion during metabolic stress associated with beta 1-adrenoceptor stimulation.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Denopamine
CAS:71771-90-9 |
C18H23NO4 |
Binding pockets of the beta(1)- and beta(2)-adrenergic recep...
1999-11-01 [Mol. Pharmacol. 56 , 875-885, (1999)] |
Regioselective glucuronidation of denopamine: marked species...
2005-03-01 [Drug Metab. Dispos. 33(3) , 403-12, (2005)] |
Vascular responses to beta-adrenoceptor subtype-selective ag...
2001-02-01 [J. Auton. Pharmacol. 21(1) , 7-13, (2001)] |
Denopamine stimulates alveolar fluid clearance via cystic fi...
2006-09-01 [Respirology 11(5) , 566-71, (2006)] |
Denopamine, a selective beta1-receptor agonist and a new cor...
2002-01-01 [Curr. Med. Res. Opin. 18(7) , 407-13, (2002)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved